Clinical features of MS associated with Leber hereditary optic neuropathy mtDNA mutations

Neurology

Volumn 81, Issue 24, 2013, Pages 2073-2081

  Pfeffer, Gerald ^a   Burke, Ailbhe ^b   Yu Wai Man, Patrick ^a   Compston, D Alastair S ^c   Chinnery, Patrick F ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; EYE PAIN; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; LEBER HEREDITARY OPTIC NEUROPATHY; MALE; MULTIPLE SCLEROSIS; OPTIC NEURITIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; VISUAL ACUITY; VISUAL IMPAIRMENT; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; DNA, MITOCHONDRIAL; FEMALE; GREAT BRITAIN; HUMANS; MALE; MULTIPLE SCLEROSIS; MUTATION; OPTIC ATROPHY, HEREDITARY, LEBER; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84892163199     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0000437308.22603.43     Document Type: Article

References (40)

1. Kirkman MA, Korsten A, Leonhardt M, et al. Quality of life in patients with Leber hereditary optic neuropathy. Invest Ophthalmol Vis Sci 2009;50:3112-3115.
2. Harding AE, Sweeney MG, Miller DH, et al. Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation. Brain 1992;115(pt 4):979-989.
3. Kellar-Wood H, Robertson N, Govan GG, Compston DA, Harding AE. Leber's hereditary optic neuropathy mitochondrial DNA mutations in multiple sclerosis. Ann Neurol 1994;36:109-112. (Pubitemid 24205833)
4. Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol 1999;19:28-33. (Pubitemid 30249281)
5. Man PY, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet 2003;72:333-339. (Pubitemid 36194242)
6. Puomila A, Hamalainen P, Kivioja S, et al. Epidemiology and penetrance of Leber hereditary optic neuropathy in Finland. Eur J Hum Genet 2007;15:1079-1089. (Pubitemid 47491463)
7. Spruijt L, Kolbach DN, de Coo RF, et al. Influence of mutation type on clinical expression of Leber hereditary optic neuropathy. Am J Ophthalmol 2006;141:676-682.
8. Vanopdenbosch L, Dubois B, D'Hooghe MB, Meire F, Carton H. Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis. J Neurol 2000;247:535-543. (Pubitemid 30598881)
9. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011;69:292-302.
10. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-March 2000. Eye 2008; 22:905-911.
11. Carrara F, Eoli M, La Mantia L, Zeviani M. The contribution of LHON mitochondrial DNA mutations to multiple sclerosis. Am J Hum Genet 1995;57:A336.
12. Kalman B, Rodriguez-Valdez JL, Bosch U, Lublin FD. Screening for Leber's hereditary optic neuropathy associated mitochondrial DNA mutations in patients with prominent optic neuritis. Mult Scler 1997;2:279-282.
13. Leuzzi V, Carducci C, Lenza M, et al. LHON mutations in Italian patients affected by multiple sclerosis. Acta Neurol Scand 1997;96:145-148. (Pubitemid 27375021)
14. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008;83:254-260.
15. Man PY, Turnbull DM, Chinnery PF. Leber hereditary optic neuropathy. J Med Genet 2002;39:162-169. (Pubitemid 34252551)
16. McDonald WI, Barnes D. The ocular manifestations of multiple sclerosis: 1: abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry 1992;55:747-752.
17. Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the Optic Neuritis Treatment Trial. Arch Ophthalmol 1991;109:1673-1678.
18. Hirst C, Ingram G, Pickersgill T, Swingler R, Compston DA, Robertson NP. Increasing prevalence and incidence of multiple sclerosis in South East Wales. J Neurol Neurosurg Psychiatry 2009;80:386-391.
19. Yu-Wai-Man P, Griffiths PG, Gorman GS, et al. Multisystem neurological disease is common in patients with OPA1 mutations. Brain 2010;133(pt 3):771-786.
20. Carelli V, Ghelli A, Ratta M, et al. Leber's hereditary optic neuropathy: biochemical effect of 11778/ND4 and 3460/ND1 mutations and correlation with the mitochondrial genotype. Neurology 1997;48:1623-1632.
21. Mahad D, Ziabreva I, Lassmann H, Turnbull D. Mitochondrial defects in acute multiple sclerosis lesions. Brain 2008;131(pt 7):1722-1735. (Pubitemid 351957459)
22. Mahad DJ, Ziabreva I, Campbell G, et al. Mitochondrial changes within axons in multiple sclerosis. Brain 2009;132 (pt 5):1161-1174.
23. Dabhi VM, Lindahl KF. MtDNA-encoded histocompatibility antigens. Methods Enzymol 1995;260:466-485.
24. Klopstock T, Metz G, Yu-Wai-Man P, et al. Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy. Brain 2013;136(pt 2):e230.
25. Katrych O, Simone TM, Azad S, Mousa SA. Diseasemodifying agents in the treatment of multiple sclerosis: a review of long-term outcomes. CNS Neurol Disord Drug Targets 2009;8:512-519.
26. Cortelli P, Montagna P, Pierangeli G, et al. Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study. J Neurol Sci 1997;148:25-31. (Pubitemid 27149521)
27. Perez F, Anne O, Debruxelles S, et al. Leber's optic neuropathy associated with disseminated white matter disease: a case report and review. Clin Neurol Neurosurg 2009; 111:83-86.
28. Buhmann C, Gbadamosi J, Heesen C. Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapy. Acta Neurol Scand 2002;106:236-239.
29. Marriott JJ, Miyasaki JM, Gronseth G, O'Connor PW; Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Evidence Report: the efficacy and safety of mitoxantrone (Novantrone) in the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2010;74: 1463-1470.
30. Horton L, Conger A, Conger D, et al. Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy. Neurology 2013;80:1862-1866.
31. Hanefeld FA, Ernst BP, Wilichowski E, Christen HJ. Leber's hereditary optic neuropathy mitochondrial DNA mutations in childhood multiple sclerosis. Neuropediatrics 1994;25:331.
32. Nishimura M, Obayashi H, Ohta M, Uchiyama T, Hao Q, Saida T. No association of the 11778 mitochondrial DNA mutation and multiple sclerosis in Japan. Neurology 1995;45:1333-1334.
33. Kalman B, Lublin FD, Alder H. Mitochondrial DNA mutations in multiple sclerosis. Mult Scler 1995;1:32-36.
34. Sartore M, Grasso M, Piccolo G, et al. Leber's hereditary optic neuropathy (LHON)-related mitochondrial DNA sequence changes in Italian patients presenting with sporadic bilateral optic neuritis. Biochem Mol Med 1995;56: 45-51.
35. Mayr-Wohlfart U, Paulus C, Henneberg A, Rodel G. Mitochondrial DNA mutations in multiple sclerosis patients with severe optic involvement. Acta Neurol Scand 1996;94:167-171. (Pubitemid 26330355)
36. Chalmers RM, Robertson N, Compston DAS, Harding AE. Sequence of mitochondrial DNA in patients with multiple sclerosis. Ann Neurol 1996;40:239-243. (Pubitemid 26274560)
37. Kalman B, Lublin FD, Alder H. Characterization of the mitochondrial DNA in patients with multiple sclerosis. J Neurol Sci 1996;140(1-2):75-84.
38. Wilichowski E, Ohlenbusch A, Hanefeld F. Characterization of the mitochondrial genome in childhood multiple sclerosis: II: multiple sclerosis without optic neuritis and LHON-associated genes. Neuropediatrics 1998;29: 307-312. (Pubitemid 29054566)
39. Ohlenbusch A, Wilichowski E, Hanefeld F. Characterization of the mitochondrial genome in childhood multiple sclerosis: I: optic neuritis and LHON mutations. Neuropediatrics 1998;29:175-179. (Pubitemid 28396067)
40. Kalman B, Li S, Chatterjee D, et al. Large scale screening of the mitochondrial DNA reveals no pathogenic mutations but a haplotype associated with multiple sclerosis in Caucasians. Acta Neurol Scand 1999;99:16-25. (Pubitemid 29012613)